These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31027503)

  • 1. Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis.
    Liou TG; Adler FR; Argel N; Asfour F; Brown PS; Chatfield BA; Daines CL; Durham D; Francis JA; Glover B; Heynekamp T; Hoidal JR; Jensen JL; Keogh R; Kopecky CM; Lechtzin N; Li Y; Lysinger J; Molina O; Nakamura C; Packer KA; Poch KR; Quittner AL; Radford P; Redway AJ; Sagel SD; Sprandel S; Taylor-Cousar JL; Vroom JB; Yoshikawa R; Clancy JP; Elborn JS; Olivier KN; Cox DR
    BMC Med Res Methodol; 2019 Apr; 19(1):88. PubMed ID: 31027503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
    Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
    Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early detection of non-tuberculous mycobacteria in children with cystic fibrosis using induced sputum at annual review.
    Ahmed MI; Kulkarni H; Shajpal S; Patel D; Patel P; Claydon A; Modha DE; Gaillard EA
    Pediatr Pulmonol; 2019 Mar; 54(3):257-263. PubMed ID: 30561865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
    Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
    mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
    Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
    Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study.
    Wolter DJ; Onchiri FM; Emerson J; Precit MR; Lee M; McNamara S; Nay L; Blackledge M; Uluer A; Orenstein DM; Mann M; Hoover W; Gibson RL; Burns JL; Hoffman LR;
    Lancet Respir Med; 2019 Dec; 7(12):1027-1038. PubMed ID: 31727592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between pulmonary function and sputum biomarkers in cystic fibrosis.
    Mayer-Hamblett N; Aitken ML; Accurso FJ; Kronmal RA; Konstan MW; Burns JL; Sagel SD; Ramsey BW
    Am J Respir Crit Care Med; 2007 Apr; 175(8):822-8. PubMed ID: 17234902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.
    Majka G; Mazurek H; Strus M; Ciszek-Lenda M; Szatanek R; Pac A; Golińska E; Marcinkiewicz J
    Clin Exp Immunol; 2021 Sep; 205(3):391-405. PubMed ID: 34031873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.
    Neubauer C; Kasi AS; Grahl N; Sessions AL; Kopf SH; Kato R; Hogan DA; Newman DK
    J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia.
    Ratjen F; Waters V; Klingel M; McDonald N; Dell S; Leahy TR; Yau Y; Grasemann H
    Eur Respir J; 2016 Mar; 47(3):829-36. PubMed ID: 26585432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sputum club cell protein concentration is associated with pulmonary exacerbation in cystic fibrosis.
    Laguna TA; Williams CB; Brandy KR; Welchlin-Bradford C; Moen CE; Reilly CS; Wendt CH
    J Cyst Fibros; 2015 May; 14(3):334-40. PubMed ID: 25456770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Interactions in the Cystic Fibrosis Airway.
    Granchelli AM; Adler FR; Keogh RH; Kartsonaki C; Cox DR; Liou TG
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29769279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sputum biomarkers and the prediction of clinical outcomes in patients with cystic fibrosis.
    Liou TG; Adler FR; Keogh RH; Li Y; Jensen JL; Walsh W; Packer K; Clark T; Carveth H; Chen J; Rogers SL; Lane C; Moore J; Sturrock A; Paine R; Cox DR; Hoidal JR
    PLoS One; 2012; 7(8):e42748. PubMed ID: 22916155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Italian Cystic Fibrosis Registry (ICFR). Report 2015-2016].
    Giordani B; Amato A; Majo F; Ferrari G; Quattrucci S; Minicucci L; Padoan R; Floridia G; Salvatore D; Carnovale V; Puppo Fornaro G; Taruscio D; Salvatore M;
    Epidemiol Prev; 2019; 43(4S1):1-36. PubMed ID: 31370382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and microbiological characteristics of cystic fibrosis adults never colonized by Pseudomonas aeruginosa: Analysis of the French CF registry.
    Vongthilath R; Richaud Thiriez B; Dehillotte C; Lemonnier L; Guillien A; Degano B; Dalphin ML; Dalphin JC; Plésiat P
    PLoS One; 2019; 14(1):e0210201. PubMed ID: 30620748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening practices for nontuberculous mycobacteria at US cystic fibrosis centers.
    Low D; Wilson DA; Flume PA
    J Cyst Fibros; 2020 Jul; 19(4):569-574. PubMed ID: 32178969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of microbiota analysis in clinical trials for cystic fibrosis lung infection: Experience from the OligoG phase 2b clinical trials.
    Weiser R; Rye PD; Mahenthiralingam E
    J Microbiol Methods; 2021 Feb; 181():106133. PubMed ID: 33421446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.